Home Health, ADRD, Telehealth, and Patient Outcomes
家庭健康、ADRD、远程医疗和患者结果
基本信息
- 批准号:10513268
- 负责人:
- 金额:$ 72.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdoptedAdoptionAdvocateAlzheimer&aposs DiseaseBiological MonitoringBloodBluetoothCOVID-19COVID-19 pandemicCaregiversCaringCase MixesCharacteristicsChronic Obstructive Pulmonary DiseaseCommunicationCongressesDataData ReportingData SourcesDementiaFamilyFutureHealthHeart DiseasesHomeHome Care ServicesHome Health AgencyHome Health Care AgenciesIndustryLinkMeasuresMedicareMedicare claimMethodologyModalityMonitorNatural experimentOccupational TherapyOutcomeOwnershipOxygenPatient MonitoringPatient-Focused OutcomesPatientsPatternPenetrationPersonsPhysical therapyPoliciesPolicy MakerPopulationPrevalenceProviderReportingRiskServicesStatistical Data InterpretationStrokeSurveysTechnologyTestingVisitVoicebasecohortcoronavirus diseasecostevidence baseexperiencehandheld mobile devicehospice environmentimprovedinsightmemberpatient home carepaymentremote patient monitoringtelehealthtelehealthcaretraditional caretransmission processtrendvideo visitvirtual visitwound treatment
项目摘要
PROJECT SUMMARY/ABSTRACT
Close to 40% of home health patients have been identified as persons with Alzheimer’s Disease or Related
Dementias (ADRD). As the prevalence of ADRD in the population in general is expected to double by 2050, so
will the percent of patients with ADRD treated by home health agencies.
During the Covid-19 pandemic many home health agencies have begun using telehealth technologies,
including virtual visits and biomonitoring, to augment and partially substitute in-person, traditional care. This is
an acceleration of a trend that began over a decade earlier. A survey has found that by July of 2020, 49% of
agencies used some form of telehealth.
These two emerging trends, the expected increase in patients with ADRD on the one hand and the increased
penetration and utilization of TH by HHAs on the other, raise questions about whether the two are compatible.
Can home health care provided via telehealth to patients with ADRD be as good as the care provided to these
patients in person? Would it be comparable in terms of patients’ health outcomes and patients’ experience?
These questions have not been addressed to-date.
Furthermore, there is no information about the type of agencies that adopted telehealth, and in particular
among those agencies that care for a majority of ADRD patients. There is also no information about the
differences in types of telehealth technologies (e.g. communication telehealth versus biomonitoring) that were
adopted.
This study will address these questions by: 1.) performing a national survey of home health agencies caring for
a majority of patients with ADRD about their telehealth capabilities and use, and the timing of telehealth
adoption; 2.) linking survey data to agency characteristics, patients’ health outcomes and patients’ experience
data; 3.) analyzing the data statistically to identify agency characteristics associated with different stages of
telehealth adoption, the association between telehealth and better patients’ health outcomes and experiences,
and the relative ranking of specific telehealth technologies in terms of their association with better patients’
health outcomes and better patients experiences.
The information gained in this study will inform home health patients and families, advocates, the industry and
CMS, as the issue of payment for telehealth services for home health is moving forward towards consideration
by Congress and will influence federal and state policies in the coming years.
项目摘要/摘要
近40%的家庭健康患者已被确认为阿尔茨海默病或相关患者
痴呆(ADRD)。由于ADRD在一般人群中的流行率预计到2050年将翻一番,因此
家庭卫生机构治疗的ADRD患者的百分比将会增加吗?
在新冠肺炎大流行期间,许多家庭健康机构已经开始使用远程医疗技术,
包括虚拟访问和生物监测,以增强并部分取代面对面的传统护理。这是
这是十多年前开始的一种趋势的加速。一项调查发现,到2020年7月,49%的
机构使用了某种形式的远程医疗。
这两个正在出现的趋势,一方面是预计ADRD患者的增加,另一方面是增加
另一方面,HHA对TH的渗透和利用,引发了两者是否兼容的问题。
通过远程保健向ADRD患者提供的家庭保健能否像向这些患者提供的护理一样好
病人要亲自来吗?在患者的健康结果和患者的体验方面,它是否具有可比性?
这些问题到目前为止还没有得到解决。
此外,没有关于采用远程保健的机构类型的信息,尤其是
在那些照顾大多数ADRD患者的机构中。也没有关于
远程保健技术类型的差异(例如,通信远程保健与生物监测)
领养的。
这项研究将通过以下方式解决这些问题:1)对关心以下问题的家庭健康机构进行全国性调查
大多数ADRD患者了解他们的远程医疗能力和使用情况,以及远程医疗的时机
领养;2.)将调查数据与机构特征、患者的健康结果和患者的经历联系起来
数据;3.)对数据进行统计分析以识别与不同阶段相关的代理特征
远程保健采用,远程保健与患者更好的健康结果和体验之间的联系,
以及特定远程医疗技术与更好的患者的关联性的相对排名
健康结果和更好的患者体验。
从这项研究中获得的信息将告知家庭健康患者和家庭、倡导者、行业和
CMS,因为家庭保健远程保健服务的付款问题正在走向审议
并将在未来几年影响联邦和州的政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANA B MUKAMEL其他文献
DANA B MUKAMEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANA B MUKAMEL', 18)}}的其他基金
Home Health, ADRD, Telehealth, and Patient Outcomes
家庭健康、ADRD、远程医疗和患者结果
- 批准号:
10689783 - 财政年份:2022
- 资助金额:
$ 72.79万 - 项目类别:
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10621699 - 财政年份:2020
- 资助金额:
$ 72.79万 - 项目类别:
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10171551 - 财政年份:2020
- 资助金额:
$ 72.79万 - 项目类别:
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10368160 - 财政年份:2020
- 资助金额:
$ 72.79万 - 项目类别:
The Costs of Home Health and Patient Outcomes
家庭健康的成本和患者的治疗结果
- 批准号:
9164927 - 财政年份:2016
- 资助金额:
$ 72.79万 - 项目类别:
The Costs of Home Health and Patient Outcomes
家庭健康的成本和患者的治疗结果
- 批准号:
9756259 - 财政年份:2016
- 资助金额:
$ 72.79万 - 项目类别:
Improving quality report cards through inclusion of consumers preferences
通过纳入消费者偏好来提高报告卡质量
- 批准号:
9103796 - 财政年份:2016
- 资助金额:
$ 72.79万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 72.79万 - 项目类别:
Research Grant